SeekingAlpha  Feb 10  Comment 
SeekingAlpha  Nov 14  Comment 
SeekingAlpha  Sep 28  Comment 
MedPage Today  May 13  Comment 
(MedPage Today) -- Observational studies back testosterone safety
SeekingAlpha  May 11  Comment 
The Economic Times  Mar 31  Comment 
Public broadcaster Prasar Bharati is set to sign a memorandum of understanding with Turkey’s state broadcaster TRT for content collaboration.
SeekingAlpha  Feb 9  Comment 
SeekingAlpha  Nov 16  Comment 
Benzinga  Nov 11  Comment 
Lipocine Inc. (NASDAQ: LPCN), a specialty pharmaceutical company, today announced that clinical data for LPCN 1021, an oral testosterone product candidate for testosterone replacement therapy ("TRT") in adult males for conditions associated with a...



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki